Artículos de revistas
BICAP tumor probe en el tratamiento paliativo de la estenosis esofágicas malignas
Autor
Catán G,Felipe
Uribe M,Mario
Carvajal H,Carlos
Cavalleri B,Silvana
Pizarro I,Francisco
Uribe L,Juan Pablo
Uribe-Echevarría A,Sebastián
López H,Cristián
Venegas D,Lorena
Institución
Resumen
Background: BICAP tumor probe is a device that consists in an energy source and olives that deliver bipolar electricity. It can be used for the fulguration of esophageal tumors after endoscopic dilatation. Aim: To report the experience in the treatment of malignant esophageal stenoses using the BICAP tumor probe. Patients and methods: Patients with advanced esophageal tumors in aphagia, that were not candidates for palliative surgery were included in this study. After endoscopic dilatation, the tumor was fulgurated with the BICAP tumor probe. Results: Twenty one patients (nine male, aged 43 to 91 years old) were treated with the device. A mean of 1.3 sessions with BICAP were necessary to obtain tumor permeabilization, which was obtained in all patients. One patient died of pneumonia 15 days after the procedure. All other patients were ingesting liquid or semisolid diets after two months of follow up. Mean survival after the procedure was 3.8 months. Conclusions: Electrical fulguration of esophageal tumors is a valid therapeutic alternative in aphagic patients. (Rev Méd Chile 2000; 128: 513-8)